RISK OF IN-HOSPITAL MORTALITY DUE TO COVID-19 IN PATIENTS WITH BRONCHIAL ASTHMA: APPLICATION OF 4C MORTALITY SCALE.
I. DOMINGUEZ ZABALETA (Madrid, Spain), G. Manzanares Cavi (Madrid, Spain), W. Giron Matute (Madrid, Spain), Z. Ji (Madrid, Spain), B. Recio Moreno (Valladolid, Spain), P. Benedetti (Madrid, Spain), A. Oliva Ramos (Madrid, Spain), L. Puente Maestu (Madrid, Spain), J. De Miguel Diez (Madrid, Spain)
Source: International Congress 2022 – Comorbidities in chronic airway diseases
Session: Comorbidities in chronic airway diseases
Session type: Thematic Poster
Number: 1663
 
Rating: 
You must login to grade this presentation.
Share or cite this content
Citations should be made in the following way:
I. DOMINGUEZ ZABALETA (Madrid, Spain), G. Manzanares Cavi (Madrid, Spain), W. Giron Matute (Madrid, Spain), Z. Ji (Madrid, Spain), B. Recio Moreno (Valladolid, Spain), P. Benedetti (Madrid, Spain), A. Oliva Ramos (Madrid, Spain), L. Puente Maestu (Madrid, Spain), J. De Miguel Diez (Madrid, Spain). RISK OF IN-HOSPITAL MORTALITY DUE TO COVID-19 IN PATIENTS WITH BRONCHIAL ASTHMA: APPLICATION OF 4C MORTALITY SCALE.. 1663
You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
Related content which might interest you:
|
|